Viewing Study NCT06339008


Ignite Creation Date: 2025-12-26 @ 10:56 AM
Ignite Modification Date: 2025-12-26 @ 10:56 AM
Study NCT ID: NCT06339008
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2024-03-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module